Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines By: Benzinga via Benzinga December 11, 2014 at 14:14 PM EST Ebola-related pharma stocks were mixed Thursday amid plans announced to buy millions of doses of vaccines for the disease once the ... Read More >> Related Stocks: Biocryst Pharma Inc Gsk Plc ADR Johnson & Johnson Merck & Co Newlink Genetics Cor Sarepta Therapeutics